Keywords
FDA
blood clots
vaccine
blood clots
vaccine
Abstract
No abstract
Most read articles by the same author(s)
- Sohail Rao, Manish Singh, Paxlovid Rebound: Proposed Strategy to Prevent Reinfection Following Treatment of COVID-19 Positive Nonhospitalized Patients , DHR Proceedings: Vol. 2 No. S3 (2022): Second Quarter Editorial
- Sohail Rao, Manish Singh, Efraim Vela, COVID-19 Vaccination During Pregnancy and Breast Feeding is Safe and Effective , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Caitlin White, Manish Singh, Is There Any Advantage of Using Polyclonal vs. Monoclonal Antibodies for Passive Enhancement of Immunity in Patients with COVID-19? , DHR Proceedings: Vol. 1 No. S5 (2021): Fourth Quarter 2021
- Sohail Rao, Manish Singh, Engineering of Viruses and Pathogens for Gain-of-Function Research , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Manish Singh, Messenger RNA Vaccines are Safe & Effective and do not Modify Host DNA , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, MD, FACS, Why Should Vaccinated People Wear Masks Indoors in Areas of High Community Transmission , DHR Proceedings: Vol. 1 No. S4 (2021): Special Publication
- Sohail Rao, Manish Singh, Manish Singh, What is the Definition of being Fully Vaccinated? , DHR Proceedings: Vol. 1 No. S5 (2021): Fourth Quarter 2021
- Sohail Rao, Manish Singh, Khushboo Hemnani, Carlos Arroyo, Can we Abandon our Masks? Deciphering CDC’s New Guidelines about Masking , DHR Proceedings: Vol. 2 No. S1 (2022): First Quarter 2022
- Sohail Rao, Challenges and Opportunities in Conducting Translational and Clinical Research in Academic Institutions and Universities , DHR Proceedings: Vol. 2 No. S1 (2022): First Quarter 2022